Indian pharmaceutical Small and Medium Enterprises (SMEs) were traditionally less transnationalized as compared to their large counterparts. National market was their primary focus and their cost-based competitive strategies were sufficient in providing them a sustainable growth within the protective domestic environment created by strong policy interventions. With large scale liberalization measures since 1990s these SMEs are now exposed to global competition ...